Home > Products > CD3 & gpA33 > Human Anti-CD3 x Anti-gpA33 Bispecific Antibody (IgG-IgG)

Human Anti-CD3 x Anti-gpA33 Bispecific Antibody (IgG-IgG)  (BSIG-H260)

Anti-CD3 x Anti-gpA33 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD3 and anti-gpA33 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Non-Hodgkin's lymphoma (NHL) therapy.

Specifications

Targets
CD3 & gpA33
Type
IgG-IgG
Species Reactivity
Human
Target 1
CD3
Host Animal 1
Human
Target 2
gpA33
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Non-Hodgkin's lymphoma (NHL)

Targets

Target 1
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3
Target 2
gpA33
Gene ID
UniProt ID
Alternative Names
GPA33; glycoprotein A33; glycoprotein A33 (transmembrane); A33; cell surface A33 antigen; transmembrane glycoprotein A33

Customer Reviews and Q&As

There are currently no customer reviews or questions for Human Anti-CD3 x Anti-gpA33 Bispecific Antibody (IgG-IgG) (BSIG-H260). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD3 & gpA33"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: